Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2023

BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) Preclinical Study on Inhaled NanoAb COVID-19 Therapy Shows Elimination of Virus from Lungs

Posted on January 17, 2023 by MissionIR

Mainland China is experiencing a fresh wave of COVID-19 infections sweeping some of its most populous provinces. The SARS-CoV-2 virus, which causes COVID-19, has been spreading fast since the Chinese government in early December lifted restrictions that were aimed at … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) CEO, Thomas Larsen, Featured in Interview with Commodity TV During the Mines and More Conference

Posted on January 17, 2023 by MissionIR

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company focused solely on its key Bolivian property, ISKA ISKA, was a featured presenter at the recent Mines and Money London conference. Held between Nov. 29 … Continue reading →

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) NanoAb Pipeline Targeting Large Underserved Medical Needs

Posted on January 13, 2023 by MissionIR

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently announced statistically significant (p<0.001) efficacy results in a preclinical in-vivo proof-of-concept study of its innovative … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Eyes Opportunity Following Recent Exploratory Work at Its Iska Iska Project

Posted on January 13, 2023 by MissionIR

Eloro Resources’ (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) EVP of Exploration Bill Pearson was recently part of an interview on Business TV (“BTV”) where he expressed his optimism on the company’s prospects following its recent exploratory work at its Iska … Continue reading →

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

MissionIRNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) CEO Reports on Company Accomplishments, Outlook through Shareholder Letter

Posted on January 13, 2023 by MissionIR

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, is in an ideal position to be “profitable” in 2023. That was the outlook reported in a shareholder letter released by JUPW CEO Brian John. The letter … Continue reading →

Posted in Jupiter Wellness Inc. JUPW | Leave a comment

MissionIRNewsBreaks – Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) CEO Featured on Gamechangers LIVE(R)

Posted on January 13, 2023 by MissionIR

Cerberus Sentinel (NASDAQ: CISO) founder and CEO David Jemmett was featured on a recent episode of Gamechangers LIVE(R) with host Sergio Tigera. The podcast series shines a spotlight on individuals who are gamechangers in their fields and shares perspectives on … Continue reading →

Posted in Cerberus Cyber Sentinel Corp. CISO | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves Closer Toward Broad Applications of Patented DehydraTECH(TM)

Posted on January 12, 2023 by MissionIR

Lexaria Bioscience Corp. (NASDAQ: LEXX) in 2022 achieved crucial milestones centered around its patented DehydraTECH(TM) drug delivery technology. “For Lexaria, the end goal does not only lie in uncovering DehydraTECH’s ability to improve the bioavailability of various APIs. Instead, the … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin to Be Evaluated in Investigator-Initiated Phase 1b/2 Trial

Posted on January 12, 2023 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced an investigator-initiated phase 1b /2 trial evaluating the company’s novel anthracycline, Berubicin. … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Vision Energy Corp. (VENG) Issues Update on Recent Market Activity

Posted on January 12, 2023 by MissionIR

Vision Energy (OTC: VENG) (the “Company”) today issued statements regarding recent removal from the OTCQB Market. On Dec. 6, 2022, Vision Energy was informed by the OTC Markets Group Inc. of certain promotional material that encouraged investors to purchase or … Continue reading →

Posted in Vision Energy Corp. VENG | Leave a comment

MissionIRNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Moves to Acquire MeridianBet Group

Posted on January 12, 2023 by MissionIR

Golden Matrix Group (NASDAQ: GMGI) is a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content. The company today announced its entry into a definitive acquisition agreement pursuant to which it has agreed to … Continue reading →

Posted in Golden Matrix Group Inc. GMGI | Leave a comment